Page last updated: 2024-08-23

substance p and 4-phenyl-3-butenoic acid

substance p has been researched along with 4-phenyl-3-butenoic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barrett, LT; May, SW; Moore, AB; O'Bryant, CL; Ogonowski, AA; Pollock, SH1
Bolkenius, FN; Chanal, MC; Danzin, C; Ganzhorn, AJ1
Abou-Mohamed, GA; Caldwell, RB; Caldwell, RW; Huang, J; Jin, L; May, SW; Oldham, CD; Taylor, TA1
Bauer, JD; Cutler, SJ; Foster, MS; May, SW; Ogonowski, AA; Pollock, SH; Sunman, JA; Thompson, JR1
Burns, TJ; Lucrezi, JD; Matesic, DF; May, SW; Oldham, CD1

Other Studies

5 other study(ies) available for substance p and 4-phenyl-3-butenoic acid

ArticleYear
Antiinflammatory and analgesic activity of an inhibitor of neuropeptide amidation.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 280, Issue:2

    Topics: Amidine-Lyases; Amino Acid Sequence; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Carrageenan; Edema; Fatty Acids, Monounsaturated; Inflammation; Kinetics; Lyases; Male; Mice; Mixed Function Oxygenases; Multienzyme Complexes; Rats; Rats, Sprague-Dawley; Serotonin; Substance P; Substrate Specificity

1997
Selective mechanism-based inactivation of peptidylglycine alpha-hydroxylating monooxygenase in serum and heart atrium vs. brain.
    Biochemical pharmacology, 1997, Jun-01, Volume: 53, Issue:11

    Topics: Animals; Brain; Fatty Acids, Monounsaturated; Heart Atria; Horses; Humans; Hydrazines; Hydrogen-Ion Concentration; Kinetics; Male; Mixed Function Oxygenases; Multienzyme Complexes; Myocardium; Rats; Rats, Sprague-Dawley; Species Specificity; Substance P; Sulfhydryl Compounds

1997
Vascular and endothelial actions of inhibitors of substance P amidation.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:6

    Topics: Amidine-Lyases; Animals; Aorta, Thoracic; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Monounsaturated; In Vitro Techniques; Male; Mixed Function Oxygenases; Multienzyme Complexes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rabbits; Rats; Rats, Sprague-Dawley; Substance P; Vasodilation

2000
Anti-inflammatory effects of 4-phenyl-3-butenoic acid and 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester, potential inhibitors of neuropeptide bioactivation.
    The Journal of pharmacology and experimental therapeutics, 2007, Volume: 320, Issue:3

    Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Caproates; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Edema; Esters; Fatty Acids, Monounsaturated; Group II Phospholipases A2; Humans; In Vitro Techniques; Male; Molecular Structure; Neuropeptides; Phospholipases A; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Substance P

2007
Inhibition of JNK and p38 MAPK phosphorylation by 5-(acetylamino)-4-oxo-6-phenyl-2-hexenoic acid methyl ester and 4-phenyl-butenoic acid decreases substance P-induced TNF-α upregulation in macrophages.
    International immunopharmacology, 2014, Volume: 21, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Caproates; Cell Line; Fatty Acids, Monounsaturated; Macrophages; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Staurosporine; Substance P; Tumor Necrosis Factor-alpha; Up-Regulation

2014